Physician profile
Marshall Snyder
NPI 1740913987
$2,429.92
in general payments reported to CMS, 2019-2025
8 companies · $1,687 in 2025
The $1,687 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $361 · 2024: $382 · 2025: $1,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,520 · Travel and Lodging: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,519.96 |
| Travel and Lodging | $909.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,101.75 | 2025 | |
| Smith+Nephew, INC. | $683.40 | 2023-2025 | Grafix Pl, Stravix Mesh, Collagenase Santyl |
| Stryker Corporation | $291.74 | 2024-2025 | Augment Injectable, Anchorage, Biofoam |
| Zimmer Biomet Holdings, INC. | $138.31 | 2025 | Stratum Foot Plating System |
| Abbvie INC. | $109.31 | 2023 | Dalvance |
| Kuros Biosciences USA, INC | $61.99 | 2025 | Magnetos |
| Depuy Synthes Sales INC. | $23.08 | 2024 | Minibunion |
| Mid-Atlantic Surgical Systems, LLC | $20.34 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Snyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.